Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dihao Lv

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Cancer|February 24, 2025
Integrative multi-omics and machine learning identify a robust signature for discriminating prognosis and therapeutic targets in bladder cancerZhiyong Tan, Xiaorong Chen, Yinglong Huang, et al.
Oncology Reports|December 13, 2024
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)Chadanfeng Yang, Limei Wang, Chen Gong, et al.
Cytokine|December 3, 2025
Natural killer cell-related gene signature predicts immune cell infiltration and improved survival in bladder cancerYinglong Huang, Chen Gong, Engui Yang, et al.
Cell Calcium|September 3, 2025
Silencing CALB1 enhances prostate cancer radiosensitivity via calcium-mediated mitochondrial dysfunction and cellular senescenceChen Gong, Senmao Li, Ye An, et al.
Translational Oncology|April 29, 2026
Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancerHairong Wei, Chen Gong, Zhiyong Tan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Cancer|February 24, 2025
Integrative multi-omics and machine learning identify a robust signature for discriminating prognosis and therapeutic targets in bladder cancerZhiyong Tan, Xiaorong Chen, Yinglong Huang, et al.
Oncology Reports|December 13, 2024
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)Chadanfeng Yang, Limei Wang, Chen Gong, et al.
Cytokine|December 3, 2025
Natural killer cell-related gene signature predicts immune cell infiltration and improved survival in bladder cancerYinglong Huang, Chen Gong, Engui Yang, et al.
Cell Calcium|September 3, 2025
Silencing CALB1 enhances prostate cancer radiosensitivity via calcium-mediated mitochondrial dysfunction and cellular senescenceChen Gong, Senmao Li, Ye An, et al.
Translational Oncology|April 29, 2026
Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancerHairong Wei, Chen Gong, Zhiyong Tan, et al.
Pageof 2